Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

589 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Infections occurring following IL6 blockade for the management of cytokine release syndrome in onco-hematology patients.
Valery M, Saleh K, Ecea R, Michot JM, Ribrag V, Fizazi K, Hollebecque A, Lecesne A, Ponce S, Loriot Y, Champiat S, Baldini C, Sarkozy C, Castilla-Llorente C. Valery M, et al. Among authors: saleh k. Cancer Chemother Pharmacol. 2023 Sep;92(3):229-233. doi: 10.1007/s00280-023-04551-6. Epub 2023 Jun 24. Cancer Chemother Pharmacol. 2023. PMID: 37354233
A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experience.
Saleh K, Danu A, Koscielny S, Legoupil C, Pilorge S, Castilla-Llorente C, Ghez D, Lazarovici J, Michot JM, Khalife-Saleh N, Lapierre V, Alenxandrova K, Arfi-Rouche J, Bourhis JH, Ribrag V. Saleh K, et al. Leuk Lymphoma. 2018 Nov;59(11):2580-2587. doi: 10.1080/10428194.2017.1403019. Epub 2017 Nov 22. Leuk Lymphoma. 2018. PMID: 29164977
Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B-cell lymphoma: Results of LNH-EP1 study.
Sarkozy C, Michot JM, Quivoron C, Camara-Clayette V, Danu A, Lazarovici J, El-Dakdouki Y, Saleh K, Ghez D, Rossignol J, Baldini C, Arfi-Rouche J, Romano-Martin P, Tselikas L, Varga A, Gazzah A, Hollebecque A, Lacroix L, Bahleda R, Lecourt H, Vergé V, Rahali W, Cotteret S, Soria JC, Dartigues P, Massard C, Ribrag V. Sarkozy C, et al. Among authors: saleh k. Am J Hematol. 2021 Oct 1;96(10):E376-E379. doi: 10.1002/ajh.26280. Epub 2021 Jul 10. Am J Hematol. 2021. PMID: 34165816 Free article. Clinical Trial. No abstract available.
Updates in the Treatment of Peripheral T-Cell Lymphomas.
Saleh K, Michot JM, Ribrag V. Saleh K, et al. J Exp Pharmacol. 2021 Jun 22;13:577-591. doi: 10.2147/JEP.S262344. eCollection 2021. J Exp Pharmacol. 2021. PMID: 34188559 Free PMC article. Review.
Mechanisms of Resistance to Antibody-Drug Conjugates.
Khoury R, Saleh K, Khalife N, Saleh M, Chahine C, Ibrahim R, Lecesne A. Khoury R, et al. Among authors: saleh k, saleh m. Int J Mol Sci. 2023 Jun 2;24(11):9674. doi: 10.3390/ijms24119674. Int J Mol Sci. 2023. PMID: 37298631 Free PMC article. Review.
KRASG12C mutation in metastatic colorectal cancer: a new target.
Ibrahim R, Saleh K, Chahine C, Khoury R, Khalife N, Lecesne A. Ibrahim R, et al. Among authors: saleh k. Future Oncol. 2023 Aug;19(24):1641-1643. doi: 10.2217/fon-2023-0223. Epub 2023 Aug 21. Future Oncol. 2023. PMID: 37602398 No abstract available.
589 results